info@strategicmarketresearch.com
26, Broadway, Suite 934, New York , 10004
us US: +1-315-636-4233    uk UK: +44-162-237-0614     in IN: +91-826-083-6500
smrlogonew
  • Home
  • About
    • Why SMR
    • Research Methodology
    • Media Coverage
    • Join Our Team
  • Reports
    • Aerospace and Defense
    • Agriculture
    • Automotive
    • Chemicals and Materials
    • Consumer Goods
    • Energy and Power
    • Equipment and Machinery
    • Food and Beverages
    • Healthcare
    • Information and Communication Technology
    • Semiconductor and Electronics
    • Manufacturing and Construction
  • Our Practices
    • Syndicated Research
    • Consulting Services
    • Custom Research
    • Full-time Engagement Model
  • Insights
    • Press Release
    • Blog
  • Contact
Home » Healthcare » Molecular Farming Market Size Share, Future Forecast [Latest]

Molecular Farming Market By Type (Plant, Animal); By Application (Medical Treatment, Food, Pesticide, Other); By Geography, Segment revenue estimation, Forecast, 2023-2030.

Published On: Feb-2024   |   Base Year: 2021   |   No Of Pages: 150   |   Historical Data: 2017-2020   |   Formats: PDF   |   Report ID: 55667167

The molecular farming market size in 2023 was worth USD 455.20 million and by 2030 it will be worth USD 1,196 million, growing at a 14.80% CAGR. Soaring demand for biopharmaceuticals, coupled with the efficiency and cost-effectiveness of molecular farming, is driving market growth.

 

The use of plant-based components in food and drink has become more widespread in the food business. This change entails substituting plant-based chemicals for synthetic ones, such as colorants and fragrances, as well as ingredients derived from animals. This shift has resulted in a greater dependence on traditional farming methods, raising concerns regarding sustainability. One of the most attractive applications of biotechnology in agriculture is the creation of recombinant proteins in plants, often known as molecular farming. This strategy entails genetically modifying plants to express foreign genes that code for industrial enzymes, vaccines, antibodies, and other macromolecules as well as lucrative drugs. Compared to traditional protein production techniques, molecular farming has a number of benefits, including reduced prices, scalability, safety, and environmental sustainability.

 

Molecular Farming Market By Infographics

 

Molecular farming uses plants and animals as bioreactors or factories to synthesize proteins, antibodies, vaccines, enzymes, and other biomolecules that are otherwise difficult, costly, or unethical to obtain. Molecular farming has the potential to completely transform the industries of environmental remediation, agriculture, medicine, and manufacturing. Molecular farming can save production costs as it does not require costly infrastructure, equipment, or purifying procedures. For instance, using mammalian cell culture, the production of a gram of monoclonal antibody which is commonly used for treatments and diagnostics may cost up to $1000, whereas utilizing plant-based methods, the same amount can be produced for only $10.

 

Molecular farming can create safe and effective vaccines and medicines for a variety of diseases, including malaria, COVID-19, HIV, Ebola, and cancer. For instance, Medicago, a Canadian biopharmaceutical company, has developed a plant-based COVID-19 vaccine that has demonstrated encouraging outcomes in clinical studies and is anticipated to receive approval by the end of 2024. Compared to traditional vaccinations, plant-based vaccines provide a number of benefits, including cheaper production costs, quicker scalability, and a lesser chance of contamination and allergic responses.

 

Market Driver (Plant-Based Proteins on the Rise: Molecular Farming Meeting Growing Needs)

The market growth of molecular farming is primarily driven by the rising demand for protein. The demand for protein-rich diets is increasing due to the rising world population and urbanization, particularly in developing nations where dietary patterns are altering to include more protein. To meet the rising need for protein, scalable and sustainable protein production can be attained through molecular farming. With concerns about animal welfare, sustainability, and health, there is a noticeable change in dietary habits towards plant-based diets. Consequently, there is a surge in demand for plant-based protein sources as more individuals adopt vegetarian or vegan lifestyles. Thanks to molecular farming, proteins derived from plants can now be produced to meet the needs of an expanding market. 

 

Restraints (From Regulation to Reality: Navigating Challenges in Molecular Farming)

Regulation: Due to the manipulation and alteration of live organisms and their products, molecular farming is closely regulated and ethically evaluated. For instance, approval from various agencies, including the Food and Drug Administration (FDA), the Environmental Protection Agency (EPA), and the United States Department of Agriculture (USDA), as well as adherence to the Cartagena Protocol on Biosafety, which safeguards human health and biodiversity against the possible negative impacts of genetically modified organisms (GMOs), may be necessary when producing pharmaceuticals using plants or animals.

 

Stability: Molecular farming may confront stability and consistency concerns because the quality and amount of the biomolecules produced might fluctuate based on environmental factors, genetic differences, and biological processes of the plants or animals used. For instance, low yields and decreased immunogenicity may arise from employing plants to produce vaccines because of several conditions like temperature, humidity, light, pests, and infections.

 

Opportunity (Tailor-Made Treatments: How Molecular Farming Fuels Personalized Medicine)

Medical innovation could be greatly enhanced by the rapidly developing field of personalized medicine combined with molecular farming. The need for focused treatments is growing, and the shortcomings of conventional methods present a perfect storm for this technology. The production of patient-specific proteins using molecular farming provides opportunities for the development of personalized treatments for uncommon illnesses, cancer immunotherapy, and gene therapy. The precise market size is still being determined, but the market for personalized medicine as a whole is expanding quickly, suggesting that there is a significant unmet demand. The potential advantages for patients and the healthcare system are indisputable, but there are regulatory obstacles and cost-effectiveness issues that must be resolved. This market niche is anticipated to grow as technology advances, influencing the direction of customized medicine by introducing more precise and effective treatment options.

 

Molecular Farming Market By Size

 

Molecular Farming's Growth Engine: A Deep Dive into Market Segmentation

The market for molecular farming is segmented on the basis of type, application, and region.

By Type

  • Plant

  • Animal

 

By Application

  • Medical Treatment

  • Food

  • Pesticide

  • Other

 

By Geography

  • Europe

  • North America

  • Asia Pacific

  • Middle East & Africa

  • Latin America

 

Molecular Farming Market By Type

 

Beyond Cost-Effective: The Multifaceted Advantages of Plant-Based Molecular Farming

On the basis of type, plant segments ruled the market significantly with a comprehensive market share. Plant-based molecular farming is preferred in biopharmaceutical and biotechnology sectors as it offers several advantages. Plants are affordable and scalable bioreactors to make high-value proteins, antibodies, medicines, and vaccines. Gene editing will enable even more accurate protein production; sustainable plant selection will be prioritized; and openness will be used to uphold public confidence. A greener and more flexible method of producing protein is being revolutionized by plant molecular farming.

 

Farming for the Future: Sustainable Food Production with Molecular Farming

On the basis of application, the food sector held largest position in the market. Molecular farming has potential in the food industry by improving food safety, nutritional content, and the creation of functional foods. It creates proteins, enzymes, and nutraceuticals from plants to fortify food products with improved nutritional profiles. Finally, molecular farming promotes ecologically friendly farming methods and supports sustainable agriculture.

 

Cultivating Innovation: Asia Pacific Leads the Molecular Farming Race

Regionally, Asia Pacific is the largest market, holding a significant revenue share. Asia Pacific is the largest market for molecular farming due to its diverse climate and abundant agricultural resources. Investments in biotechnology infrastructure and research, favorable government policies, and partnerships between government agencies, businesses, and academia have led to the expansion of the molecular farming market. 

 

North America molecular farming market is expected to expand significantly. The expansion of this sector will be greatly influenced by government financing, laws, and regulations around GMOs and plant-based agriculture. The environmentally friendly strategy of plant-based molecular farming is a wonderful fit with the increasing emphasis on sustainability.

 

The Green Giants: Unveiling the Top Players in Molecular Farming

  • ·Pharming Group NV

  • ·LFB Biotechnologies SA 

  • ·Medicargo

  • ·Pfizer

  • ·Avaxin Biologics

  • ·Mapp Biopharmaceutical

  • ·ORF Genetics

  • ·Miruku

  • ·Mozza

  • ·Bright Biotech

  • ·Nobell Foods

  • ·Tiamat Sciences

 

Molecular Farming Market By Region

 

From Labs to Fields: Recent Advances Push Molecular Farming Towards Commercialization

  • In September 2023, A FoodTech startup, BioBetter, Ltd., established its first food-grade pilot facility to speed up the production of essential growth factors for the cultured meat industry. The company has devised a unique platform for protein synthesis that creates growth factors (GFs) using tobacco plants as self-sufficient bioreactors, eliminating the need for animals.

 

  • In August 2023, ZERO and KBio formed a strategic alliance to create a portable plant-based molecular farming network. This network will produce therapeutic, pandemic preparedness, and bioactive ingredients in large, centralized hubs. ZERO's modular and contamination-free plant growing setup will be combined with KBio's expertise with N. benthamiana as a bioreactor to create customized end-to-end solutions.

Frequently Asked Question About This Report

Molecular farming safety considerations include: • Public concerns about GMO safety, requiring transparency and education. • Accidental release of modified plants into the environment, necessitating strict protocols. • Potential for allergens from host plants, demanding careful plant selection and testing. • Risk of endotoxins from bacteria, requiring optimized purification processes.

The global molecular farming Market Size in 2023 was worth USD 1.65 Billion and by 2029 it will be worth USD 2.5 Billion, growing at a 7.85% CAGR.

Asia Pacific currently holds the largest market share due to its diverse climate, abundant agricultural resources, and supportive government policies. Investments in research and infrastructure, along with partnerships between different sectors, are fueling growth in this region.

Investment in research infrastructure and supportive policies regarding GMOs and plant-based agriculture can accelerate market growth.

Emerging technologies set to impact molecular farming include: • Gene editing (CRISPR) for precise protein production. • Sustainable plant choices to minimize environmental impact. • Transparency to build public trust in GMO safety.

.


Table of Contents

1.    EXECUTIVE SUMMARY
1.1. Market Attractiveness
1.2. Understanding the Target Customers
1.3. CXO perspective
1.4. Global Molecular Farming Market, Historical Market Size & Future Projections Analysis
1.5. Global Molecular Farming Market, By Type
1.6. Global Molecular Farming Market, By Application
1.7. Global Molecular Farming Market, By Region
2.    MARKET SHARE ANALYSIS
2.1. Top 10 Players with Revenue and Sales Volume
2.2. Market Share, 2024
3.    SALES VOLUME (METRIC TONNES), BY REGION
3.1. Europe (UK, Germany, France, Netherlands, Italy, Spain, Belgium, Sweden, Denmark, Norway, Aland Islands, Rest of Europe)
3.2. Asia (China, Japan, South Korea, India, Indonesia, Rest of Asia)
3.3. Middle-East (Israel, Saudi Arabia, UAE, Qatar, Egypt, Kuwait, Bahrain, and Others)
4.    INVESTMENT OPPORTUNITIES IN THE MARKET
4.1. On Going Market Developments
4.2. Merger & Acquisition Trends
4.3. Key Investment Opportunities
4.4. Most Potential Product Type Segments from Growth and Investment Perspective
5.    MARKET INTRODUCTION
5.1. Definition
5.2. Scope of the Study
5.3. Market Structure
5.4. Macro Factor Indicator Analysis
5.5. Key findings
5.5.1. Top investment pockets
6.    RESEARCH METHODOLOGY
6.1. Research Process
6.2. Primary Research
6.3. Secondary Research
6.4. Market Size Estimation
6.5. Forecast Model
7.    MARKET DYNAMICS
7.1. Introduction
7.2. Drivers
7.3. Restraints
7.4. Opportunities
7.5. Challenges 
7.6. Covid 19 Impact Analysis
8.    GLOBAL MOLECULAR FARMING MARKET ANALYSIS BY SEGMENT (REGION LEVEL ANALYSIS)
8.1. Overview
8.2. Global Molecular Farming Historical Market size ($MILLION), Sales Volume, (2022 – 2032)
8.3. Global Molecular Farming Market size ($MILLION), Sales Volume, and Forecasts (2024 – 2032)
8.4. Global Molecular Farming Market size ($MILLION), Sales Volume, and Forecasts (2024 – 2032), By Type
8.4.1. Plant
8.4.2. Animal
8.5. Global Molecular Farming Market size ($MILLION), Sales Volume, and Forecasts (2024 – 2032), By Application
8.5.1. Medical Treatment
8.5.2. Food
8.5.3. Pesticide
8.5.4. Others
8.6. Global Molecular Farming Market size ($MILLION), Sales Volume, and Forecasts (2024 – 2032), By Geography
8.6.1. Asia 
8.6.2. North America
8.6.3. Europe
8.6.4. Middle East
9.    NORTH AMERICA MOLECULAR FARMING MARKET ANALYSIS BY SEGMENT (REGION LEVEL ANALYSIS)
9.1. Overview
9.2. North America Molecular Farming Historical Market size ($MILLION), Sales Volume, (2022 – 2032)
9.3. North America Molecular Farming Market size ($MILLION), Sales Volume, and Forecasts (2024 – 2032)
9.4. North America Molecular Farming Market size ($MILLION), Sales Volume, and Forecasts (2024 – 2032), By Type
9.4.1. Plant
9.4.2. Animal
9.5. North America Molecular Farming Market size ($MILLION), Sales Volume, and Forecasts (2024 – 2032), By Application
9.5.1. Medical Treatment
9.5.2. Food
9.5.3. Pesticide
9.5.4. Others
9.6. North America Pesticicde Molecular Farming Market size ($MILLION), Sales Volume, and Forecasts (2024 – 2032), By Geography 
9.6.1. USA
9.6.1.1.    California
9.6.1.2.    Texas
9.6.1.3.    Florida
9.6.1.4.    Pennsylvania
9.6.1.5.    Illinois
9.6.1.6.    North Carolina
9.6.1.7.    Rest of the U.S.
9.6.2. Canada
9.6.3. Rest of North America
10.    EUROPE GLOBAL MOLECULAR FARMING MARKET ANALYSIS 
10.1. Overview
10.2. Europe Molecular Farming Historical Market size ($MILLION), Sales Volume, (2022 – 2032)
10.3. Europe Molecular Farming Market size ($MILLION), Sales Volume, and Forecasts (2024 – 2032)
10.4. Europe Molecular Farming Market size ($MILLION), Sales Volume, and Forecasts (2024 – 2032), By Type
10.4.1. Plant
10.4.2. Animal
10.5. Europe Molecular Farming Market size ($MILLION), Sales Volume, and Forecasts (2024 – 2032), By Application
10.5.1. Medical Treatment
10.5.2. Food
10.5.3. Pesticide
10.5.4. Others
10.6. Europe Molecular Farming Market size ($MILLION), Sales Volume, and Forecasts (2024 – 2032), By Region
10.6.1. Germany
10.6.2. UK
10.6.3. France
10.6.4. Spain
10.6.5. Italy
10.6.6. Benelux
10.6.7. Rest of Europe
11.    ASIA PACIFIC MOLECULAR FARMING MARKET ANALYSIS 
11.1. Overview
11.2. Asia Pacific Molecular Farming Historical Market size ($MILLION), Sales Volume, (2022 – 2032)
11.3. Asia Pacific Molecular Farming Market size ($MILLION), Sales Volume, and Forecasts (2024 – 2032)
11.4. Asia Pacific Molecular Farming Market size ($MILLION), Sales Volume, and Forecasts (2024 – 2032), By Type
11.4.1. Plant
11.4.2. Animal
11.5. Asia Pacific Molecular Farming Market size ($MILLION), Sales Volume, and Forecasts (2024 – 2032), By Application
11.5.1. Medical Treatment
11.5.2. Food
11.5.3. Pesticide
11.5.4. Others
11.6. Asia Pacific Molecular Farming Market size ($MILLION), Sales Volume, and Forecasts (2024 – 2032), By Region
11.6.1. China
11.6.2. Japan
11.6.3. Korea
11.6.4. India
11.6.5. Indonesia
11.6.6. Rest of Asia
12.    REST OF THE WORLD MOLECULAR FARMING MARKET ANALYSIS 
12.1. Overview
12.2. Rest of the World Molecular Farming Market Historical Market size ($MILLION), Sales Volume, (2022 – 2032)
12.3. Rest of the World Molecular Farming Market size ($MILLION), Sales Volume, and Forecasts (2024 – 2032)
12.4. Rest of the World Molecular Farming Market size ($MILLION), Sales Volume, and Forecasts (2024 – 2032), By Type
12.4.1. Plant
12.4.2. Animal
12.5. Rest of the World Molecular Farming Market size ($MILLION), Sales Volume, and Forecasts (2024 – 2032), By Application
12.5.1. Medical Treatment
12.5.2. Food
12.5.3. Pesticide
12.5.4. Others
12.6. Rest of the World Molecular Farming Market size ($MILLION), Sales Volume, and Forecasts (2024 – 2032), By Region
12.6.1. Latin America
12.6.2. Middle East
12.6.3. Africa   
13.    COMPANY PROFILES
13.1. PHARMING GROUP NV
13.1.1. Company Overview  
13.1.2. Company Snapshot  
13.1.3. Operating business segments
13.1.4. Product Type offered and Revenue from Global Molecular Farming Business
13.1.5. Key business performances, strategies and developments
13.2. LFB BIOTECHNOLOGIES SA
13.2.1. Company Overview  
13.2.2. Company Snapshot  
13.2.3. Operating business segments
13.2.4. Product Type offered and Revenue from Global Molecular Farming Business
13.2.5. Key business performances, strategies and developments
13.3. PFIZER
13.3.1. Company Overview
13.3.2. Company Snapshot
13.3.3. Operating business segments
13.3.4. Product Type offered and Revenue from Global Molecular Farming Business
13.3.5. Key business performances, strategies and developments
13.4.  AVAXIN BIOLOGICS
13.4.1. Company Overview
13.4.2. Company Snapshot
13.4.3. Operating business segments
13.4.4. Product Type offered and Revenue from Global Molecular Farming Business
13.4.5. Key business performances, strategies and developments
13.5. MAPP BIOPHARMACEUTICAL
13.5.1. Company Overview
13.5.2. Company Snapshot
13.5.3. Operating business segments
13.5.4. Product Type offered and Revenue from Global Molecular Farming Business
13.5.5. Key business performances, strategies and developments
13.6. ORF GENETICS
13.6.1. Company Overview
13.6.2. Company Snapshot
13.6.3. Operating business segments
13.6.4. Product Type offered and Revenue from Global Molecular Farming Business
13.6.5. Key business performances, strategies and developments
13.7. MIRUKU
13.7.1. Company Overview
13.7.2. Company Snapshot
13.7.3. Operating business segments
13.7.4. Product Type offered and Revenue from Global Molecular Farming Business
13.7.5. Key business performances, strategies and developments
13.8. BRIGHT BIOTECH
13.8.1. Company Overview
13.8.2. Company Snapshot
13.8.3. Operating business segments
13.8.4. Product Type offered and Revenue from Global Molecular Farming Business
13.8.5. Key business performances, strategies and developments
13.9. NOBELL FOODS
13.9.1. Company Overview
13.9.2. Company Snapshot
13.9.3. Operating business segments
13.9.4. Product Type offered and Revenue from Global Molecular Farming Business
13.9.5. Key business performances, strategies and developments
13.10. TIAMAT SCIENCES
13.10.1. Company Overview
13.10.2. Company Snapshot
13.10.3. Operating business segments
13.10.4. Product Type offered and Revenue from Global Molecular Farming Business
13.10.5. Key business performances, strategies and developments
13.11. OTHER MARKET PLAYERS
13.11.1. Company Overview
13.11.2. Company Snapshot
13.11.3. Operating business segments
13.11.4. Product Type offered and Revenue from Global Molecular Farming Business
13.11.5. Key business performances, strategies and developments
LIST OF TABLES 
1. TABLE: MARKET, BY TYPE, 2024-2032 (USD MILLION)
2. TABLE: MARKET FOR PLANT, BY REGION, 2024-2032 (USD MILLION)
3. TABLE: MARKET FOR ANIMAL, BY REGION, 2024-2032 (USD MILLION)


4. TABLE: MARKET, BY APPLICATION, 2024-2032 (USD MILLION)
5. TABLE: MARKET FOR MEDICAL TREATMENT, BY REGION, 2024-2032 (USD MILLION)
6. TABLE: MARKET FOR FOOD, BY REGION, 2024-2032 (USD MILLION)
7. TABLE: MARKET FOR PESTICICDE, BY REGION, 2024-2032 (USD MILLION)
8. TABLE: MARKET FOR OTHERS, BY REGION, 2024-2032 (USD MILLION)


9. TABLE: MARKET, BY REGION, 2024-2032 (USD MILLION)
10. TABLE: NORTH AMERICA MARKET, BY REGION, 2024-2032 (USD MILLION)
11. TABLE: NORTH AMERICA MARKET, BY TYPE, 2024-2032 (USD MILLION)
12. TABLE: NORTH AMERICA MARKET, BY APPLICATION, 2024-2032 (USD MILLION)


13. TABLE: USA MARKET BY TYPE, 2024-2032 (USD MILLION)
14. TABLE: USA MARKET, BY APPLICATION, 2024-2032 (USD MILLION) 

15. TABLE: CALIFORNIA MARKET, BY TYPE, 2024-2032 (USD MILLION)
16. TABLE: CALIFORNIA MARKET, BY APPLICATION, 2024-2032 (USD MILLION)

17. TABLE: TEXAS MARKET BY TYPE, 2024-2032 (USD MILLION)
18. TABLE: TEXAS MARKET, BY APPLICATION, 2024-2032 (USD MILLION)  

19. TABLE: FLORIDA MARKET, BY TYPE, 2024-2032 (USD MILLION)
20. TABLE: FLORIDA MARKET, BY APPLICATION, 2024-2032 (USD MILLION)  

21. TABLE: CANADA MARKET, BY TYPE, 2024-2032 (USD MILLION)
22. TABLE: CANADA MARKET, BY APPLICATION, 2024-2032 (USD MILLION) 

23. TABLE: MEXICO MARKET, BY TYPE, 2024-2032 (USD MILLION) 
24. TABLE: MEXICO MARKET, BY APPLICATION, 2024-2032 (USD MILLION) 


25. TABLE: REST OF NORTH AMERICA MARKET, BY TYPE, 2024-2032 (USD MILLION)
26. TABLE: REST OF NORTH AMERICA MARKET, BY APPLICATION, 2024-2032 (USD MILLION)


27. TABLE: EUROPE MARKET, BY REGION, 2024-2032 (USD MILLION)
28. TABLE: EUROPE MARKET, BY TYPE, 2024-2032 (USD MILLION)
29. TABLE: EUROPE MARKET, BY APPLICATION, 2024-2032 (USD MILLION)

30. TABLE: UK MARKET, BY TYPE, 2024-2032 (USD MILLION)
31. TABLE: UK MARKET, BY APPLICATION, 2024-2032 (USD MILLION)


32. TABLE: SPAIN MARKET, BY TYPE, 2024-2032 (USD MILLION)
33. TABLE: SPAIN MARKET, BY APPLICATION, 2024-2032 (USD MILLION)  


34. TABLE: BELGIUM MARKET, BY TYPE, 2024-2032 (USD MILLION)
35. TABLE: BELGIUM MARKET, BY APPLICATION, 2024-2032 (USD MILLION) 


36. TABLE: SCANDINAVIAN MARKET, BY TYPE, 2024-2032 (USD MILLION)
37. TABLE: SCANDINAVIAN MARKET, BY APPLICATION, 2024-2032 (USD MILLION) 


38. TABLE: GERMANY MARKET, BY TYPE, 2024-2032 (USD MILLION)
39. TABLE: GERMANY MARKET, BY APPLICATION, 2024-2032 (USD MILLION)  


40. TABLE: FRANCE MARKET, BY TYPE, 2024-2032 (USD MILLION) 
41. TABLE: FRANCE MARKET, BY APPLICATION, 2024-2032 (USD MILLION)

42. TABLE: ITALY MARKET, BY TYPE, 2024-2032 (USD MILLION)
43. TABLE: ITALY MARKET, BY APPLICATION, 2024-2032 (USD MILLION) 

44. TABLE: REST OF EUROPE MARKET, BY TYPE, 2024-2032 (USD MILLION)
45. TABLE: REST OF EUROPE MARKET, BY APPLICATION, 2024-2032 (USD MILLION)

46. TABLE: ASIA MARKET, BY TYPE, 2024-2032 (USD MILLION) 
47. TABLE: ASIA MARKET, BY APPLICATION, 2024-2032 (USD MILLION)


48. TABLE: CHINA MARKET, BY TYPE, 2024-2032 (USD MILLION)
49. TABLE: CHINA MARKET, BY APPLICATION, 2024-2032 (USD MILLION)   


50. TABLE: INDIA MARKET, BY TYPE, 2024-2032 (USD MILLION) 
51. TABLE: INDIA MARKET, BY APPLICATION, 2024-2032 (USD MILLION) 


52. TABLE: JAPAN MARKET, BY TYPE, 2024-2032 (USD MILLION)
53. TABLE: JAPAN MARKET, BY APPLICATION, 2024-2032 (USD MILLION)


54. TABLE: SOUTH KOREA MARKET, BY TYPE, 2024-2032 (USD MILLION) 
55. TABLE: SOUTH KOREA MARKET, BY APPLICATION, 2024-2032 (USD MILLION)   


56. TABLE: INDONESIA MARKET, BY TYPE, 2024-2032 (USD MILLION) 
57. TABLE: INDONESIA MARKET, BY APPLICATION, 2024-2032 (USD MILLION) 
58. TABLE: INDONESIA MARKET, BY ROUTE OF ADMINISTRATION, 2024-2032 (USD MILLION) 


59. TABLE: REST OF ASIA MARKET, BY TYPE, 2024-2032 (USD MILLION) 
60. TABLE: REST OF ASIA MARKET, BY APPLICATION, 2024-2032 (USD MILLION) 


61. TABLE: REST OF THE WORLD MARKET, BY TYPE,, 2024-2032 (USD MILLION)
62. TABLE: REST OF THE WORLD MARKET, BY APPLICATION, 2024-2032 (USD MILLION)  

63. TABLE: LFB BIOTECHNOLOGIES SA: COMPANY SNAPSHOT
64. TABLE: LFB BIOTECHNOLOGIES SA: OPERATING SEGMENTS
65. TABLE: PFIZER: COMPANY SNAPSHOT
66. TABLE: PFIZER: OPERATING SEGMENTS
67. TABLE: AVAXIN BIOLOGICS: COMPANY SNAPSHOT 
68. TABLE: AVAXIN BIOLOGICS: OPERATING SEGMENTS
69. TABLE: PHARMING GROUP NV COMPANY SNAPSHOT
70. TABLE: PHARMING GROUP NV OPERATING SEGMENTS
71. TABLE: MAPP BIOPHARMACEUTICAL: COMPANY SNAPSHOT
72. TABLE: MAPP BIOPHARMACEUTICAL: OPERATING SEGMENTS
73. TABLE: ORF GENETICS: COMPANY SNAPSHOT
74. TABLE: ORF GENETICS: OPERATING SEGMENTS
75. TABLE: MIRUKU: COMPANY SNAPSHOT
76. TABLE: MIRUKU: OPERATING SEGMENTS
77. TABLE: BRIGHT BIOTECH: COMPANY SNAPSHOT
78. TABLE: BRIGHT BIOTECH: OPERATING SEGMENTS
79. TABLE: NOBELL FOODS: COMPANY SNAPSHOT
80. TABLE: NOBELL FOODS: OPERATING SEGMENTS
81. TABLE: TIAMAT SCIENCES: COMPANY SNAPSHOT
82. TABLE: TIAMAT SCIENCES: OPERATING SEGMENTS


LIST OF FIGURES
1. Figure: Market: Research Methodology Steps
2. Figure: Research Design
3. Figure: Breakdown of Primaries: Market
4. Figure: Research Methodology: Hypothesis Building
5. Figure: Market: Product Type and Service-Based Estimation
6. Figure: Top 10 Companies with Highest No. Of Patent in Last 9 Years
7. Figure: Growth Strategies Adopted by the Key Players
8. Figure: No. of Patents Granted Per Year, 2024–2032
9. Figure: Data Triangulation Methodology
10. Figure: Dominating Market Share, By Type, 2024 vs. 2032 (USD MILLION)
11. Figure: Dominating Market Share, By Application, 2024 vs. 2032 (USD MILLION)

12. Figure: Geographical Snapshot of the Market 
13. Figure: Plant to Witness Higher Share in the Market for Type Segment during the Forecast Period.
14. Figure: Asia Pacific Accounted for the Largest Share of the Market, By Regional Basis, in 2024
15. Figure: Market: Drivers, Restraints, Opportunities, and Challenges
16. Figure: Asia: Market Snapshot
17. Figure: Europe: Market Snapshot
18. Figure: Middle East: Market Snapshot
19. Figure: Vendor Dive: Evaluation Overview
20. Figure: Molecular Farming: Competitive Benchmarking  
21. Figure: LFB Biotechnologies SA: Financial Overview (2024-2032)  
22. Figure: Pfizer: Financial Overview (2024-2032)  
23. Figure: PHARMING GROUP NV Financial Overview (2024-2032)
24. Figure: Mapp Biopharmaceutical: Financial Overview (2024-2032) 
25. Figure: ORF Genetics: Financial Overview (2024-2032)
26. Figure: Bright Biotech: Financial Overview (2024-2032) 
27. Figure: Nobell Foods: Financial Overview (2024-2032) 
28. Figure: Tiamat Sciences: Financial Overview (2024-2032)
 

Choose License Type


$4485
$6449
$8339
Buy Now
"Click to avail the latest sample copy of the report"
Request Sample
"Probe before placing the order"
Pre-Order Enquiry
"Let's optimize your ROI by furnishing the best price"
Request Discount
"Want to curate the report according to your business needs:"
Ask for Customization
Related Reports
Buy Now
Request Sample

Trust Online

  • paypal.png
  • wiretransfers

Follow Us

  • facebook
  • twitter
  • instagram
  • linkedin

Contact Us

  • US: +1-315-636-4233
  • UK: +44-162-237-0614
  • IN: +91-826-083-6500
  • info@strategicmarketresearch.com
  • Strategic Market Research
    26, Broadway Suite 934, New York , 10004

Quick Link

  • Why SMR
  • Research Methodology
  • Media Coverage
  • Join Our Team
  • Press Release
  • Blog

Customer Support

  • FAQs
  • Contact
  • Terms of Use
  • Privacy Policy
  • Disclaimer Policy
  • Return Policy
Copyright © 2022 Strategic Market Research All rights reserved.